Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>

19993,366 citationsJournal Article

Authors

Abstract

In postmenopausal women with osteoporosis, raloxifene increases bone mineral density in the spine and femoral neck and reduces risk of vertebral fracture.

Topics & Keywords

Bone health and osteoporosis research Estrogen and related hormone effects Bone Metabolism and Diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA

Volume 282, Issue 7, pp. 637-637

DOI: 10.1001/jama.282.7.637

Field-Weighted Citation Impact: 178.07

Command Palette